Align Technology (ALGN) Liabilities and Shareholders Equity (2009 - 2026)
Align Technology (ALGN) posted quarterly Liabilities and Shareholders Equity of $6.3 billion for Q1 2026, up 3.46% year-over-year from $6.1 billion in Q1 2025, and up 1.29% quarter-over-quarter from $6.2 billion in Q4 2025.
Align Technology (ALGN) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $6.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 3.46% year-over-year to $6.3 billion; the TTM figure through Mar 2026 stood at $25.0 billion (up 0.64% YoY), while the FY2025 annual figure was $6.2 billion, changed 0.31% from the prior year.
- Liabilities and Shareholders Equity climbed to $6.3 billion in Q1 2026 per ALGN's latest filing, from $6.2 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q3 2024 and bottomed at $5.8 billion in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $6.1 billion across 5 years, with a median of $6.2 billion in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity rose 17.23% — and 2025, when it declined 2.08%.
- Align Technology's Liabilities and Shareholders Equity stood at $5.9 billion in 2022, then rose by 2.29% to $6.1 billion in 2023, then advanced by 2.15% to $6.2 billion in 2024, then climbed by 0.31% to $6.2 billion in 2025, then gained by 1.29% to $6.3 billion in 2026.
- Business Quant data shows ALGN's Liabilities and Shareholders Equity at $6.3 billion in Q1 2026, $6.2 billion in Q4 2025, and $6.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 6.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.42 Bn |
| Mar 31, 2026 | 6.31 Bn |
| Dec 31, 2025 | 6.23 Bn |
| Sep 30, 2025 | 6.23 Bn |
| Jun 30, 2025 | 6.22 Bn |
| Mar 31, 2025 | 6.10 Bn |
| Dec 31, 2024 | 6.21 Bn |
| Sep 30, 2024 | 6.37 Bn |
| Jun 30, 2024 | 6.16 Bn |
| Mar 31, 2024 | 6.16 Bn |
| Dec 31, 2023 | 6.08 Bn |
| Sep 30, 2023 | 6.32 Bn |
| Jun 30, 2023 | 6.14 Bn |
| Mar 31, 2023 | 5.90 Bn |
| Dec 31, 2022 | 5.95 Bn |
| Sep 30, 2022 | 5.91 Bn |
| Jun 30, 2022 | 5.81 Bn |
| Mar 31, 2022 | 5.94 Bn |
| Dec 31, 2021 | 5.94 Bn |
| Sep 30, 2021 | 5.65 Bn |